All intellectual and work property derived from DiagnaMed’s research activities in amyotrophic lateral sclerosis (ALS) and its Orphan Drug Designation (ODD) for molecular hydrogen in the treatment of ...

Splitting water molecules takes more energy than calculations suggest, and is a key roadblock to cheap hydrogen fuel ...

Researchers have developed microneedle sensors for plants before, with some drawbacks. For instance, one microneedle patch ...

Revive Therapeutics (RVVTF) it has entered into an asset purchase agreement dated March 31 with DiagnaMed to acquire the full rights to ...

Scientists have long understood the primary way H₃⁺ forms—when a hydrogen molecule (H₂) collides with its ionized counterpart, H₂⁺.

Supercritical water, a mysterious state where water behaves like both a liquid and gas, has long puzzled scientists.

Molecular hydrogen may offer a potential therapeutic option for neurological and mental health disorders.

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive” or the "Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research ...